HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Megumi Kondo Selected Research

Pulmonary Hypertension

1/2021Efficacy of shear wave elastography for evaluating right ventricular myocardial fibrosis in monocrotaline-induced pulmonary hypertension rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Megumi Kondo Research Topics

Disease

4Fibrosis (Cirrhosis)
01/2021 - 01/2019
4Ischemia
04/2012 - 01/2009
3Pulmonary Arterial Hypertension
07/2023 - 04/2016
3Obesity
01/2015 - 01/2009
2Hypoxia (Hypoxemia)
07/2023 - 04/2016
2Inflammation (Inflammations)
01/2023 - 01/2022
2Peritoneal Fibrosis
01/2023 - 01/2020
2Heart Failure
05/2019 - 01/2019
2Cardiomegaly (Heart Hypertrophy)
05/2019 - 01/2019
2Body Weight (Weight, Body)
05/2019 - 01/2019
2Hypertrophy
05/2019 - 01/2019
1Rupture
01/2022
1Abdominal Aortic Aneurysm
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
08/2021
1Chronic Renal Insufficiency
01/2021
1Pulmonary Hypertension
01/2021
1Hypoalbuminemia
01/2021
1Hypertension (High Blood Pressure)
01/2020
1Insulin Resistance
01/2020
1Atherosclerosis
01/2020
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2019
1Vascular Calcification
08/2017
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2017
1Catheter-Related Infections
04/2016
1Spinal Cord Injuries (Spinal Cord Injury)
02/2015
1Type 2 Diabetes Mellitus (MODY)
10/2010
1Vascular Diseases (Vascular Disease)
01/2009
1Systemic Scleroderma (Systemic Sclerosis)
10/2003

Drug/Important Bio-Agent (IBA)

3MonocrotalineIBA
01/2021 - 04/2016
2Proteins (Proteins, Gene)FDA Link
07/2023 - 01/2020
2InflammasomesIBA
01/2023 - 08/2021
2(R)-2-(3-((benzoxazol-2-yl-d4 (3- (4- methoxyphenoxy- d7)propyl)amino)methyl)phenoxy) butanoic acidIBA
01/2022 - 01/2020
2pitavastatin (itavastatin)FDA Link
01/2020 - 05/2011
2Eicosapentaenoic AcidIBA
08/2017 - 01/2017
2AdiponectinIBA
10/2010 - 01/2009
1Pyruvic Acid (Pyruvate)IBA
07/2023
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
07/2023
1Adenosine Triphosphate (ATP)IBA
07/2023
1Oxidoreductases (Dehydrogenase)IBA
07/2023
1Messenger RNA (mRNA)IBA
07/2023
1Biomarkers (Surrogate Marker)IBA
01/2023
1SolutionsIBA
01/2023
1Interleukin-18 (Interleukin 18)IBA
01/2023
1CytokinesIBA
01/2023
1Glucose (Dextrose)FDA LinkGeneric
01/2023
1Angiotensin IIIBA
01/2022
1CatalaseIBA
01/2022
1PPAR alphaIBA
01/2022
1ZincIBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Receptor for Advanced Glycation End ProductsIBA
01/2021
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020
1LipidsIBA
01/2020
1LDL CholesterolIBA
01/2020
1CateninsIBA
01/2020
16- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
05/2019
1KetonesIBA
05/2019
1SaltsIBA
05/2019
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2019
1Interleukin-6 (Interleukin 6)IBA
05/2019
1Sodium-Glucose Transporter 2 InhibitorsIBA
05/2019
1Collagen Type IV (Type IV Collagen)IBA
05/2019
1Natriuretic PeptidesIBA
05/2019
1Sodium-Glucose Transport ProteinsIBA
05/2019
1Angiotensin Receptor AntagonistsIBA
01/2019
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2019
1sacubitril and valsartan sodium hydrate drug combinationIBA
01/2019
1Valsartan (Vals)FDA Link
01/2019
1Neprilysin (Neutral Endopeptidase)IBA
01/2019
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2019
1sacubitrilIBA
01/2019
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2017
1Epoprostenol (Prostacyclin)FDA LinkGeneric
04/2016
1beraprostIBA
04/2016
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2015
1N-Acetylneuraminic Acid (Sialic Acid)IBA
02/2015
1Plasminogen Activator Inhibitor 1IBA
01/2015
1Nifedipine (Adalat)FDA LinkGeneric
04/2012
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2011
1Fenofibrate (CiL)FDA LinkGeneric
10/2010
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2003

Therapy/Procedure

3Therapeutics
01/2022 - 10/2003
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2023
1Surgical Amputation (Amputations)
10/2010
1Caloric Restriction
01/2009